Treatment of MRSA infections with older molecules: a reasonable option for investigation.

摘要

In the October 2006 issue of the Archives, Hidayat et al addressed an alarming issue related to vancomycin treatment failures for infections caused by vancomycin-susceptible MRSA strains with a relatively high MIC. They suggested the use of combination or alternative therapy for invasive infections.